Strata Skin SciencesSSKN
About: Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.
Employees: 99
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
12% more funds holding
Funds holding: 17 [Q2] → 19 (+2) [Q3]
10.38% less ownership
Funds ownership: 39.33% [Q2] → 28.95% (-10.38%) [Q3]
22% less capital invested
Capital invested by funds: $4.24M [Q2] → $3.32M (-$918K) [Q3]
Research analyst outlook
We haven’t received any recent analyst ratings for SSKN.
Financial journalist opinion
Based on 4 articles about SSKN published over the past 30 days
